Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
9,633,125
-
Share change
-
+925,933
-
Total reported value
-
$883,813,866
-
Put/Call ratio
-
170%
-
Price per share
-
$91.78
-
Number of holders
-
95
-
Value change
-
+$85,593,538
-
Number of buys
-
55
-
Number of sells
-
38
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2014
As of 30 Sep 2014,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,633,125 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, FIRST TRUST ADVISORS LP, UBS AG, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, GOLDMAN SACHS GROUP INC, ROYAL BANK OF CANADA, LPL Financial LLC, and RiverFront Investment Group, LLC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.